Web www.globalrph.com
Home Back *Drug Tables Disclaimer IV Dilutions *Health topics* Professional Resource 
PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER.  References     Disclaimer  

Acyclovir
Zovirax ®
Usual Diluents
D5W,  NS
Standard Dilutions   [Amount of drug]  [Infusion volume]  [Infusion rate]
[0-350 mg]  [50 ml] [1 hour]
[351-700 mg] [100 ml] [1 hour]
Stability / Miscellaneous
EXP: 1 day (RT). (Note: conflicting data regarding estimated stability. Some studies have reported much longer stability (3- 4 weeks), while other studies confirm the stability indicated by the manufacturer (24 hours).   

Label
: Do not refrigerate.     Maximum concentration = 7 mg/ml.   

Mucocutaneous herpes simplex: IV: 5 mg/kg/dose q8h x 5-10 days. Encephalitis: 10mg/kg/dose IV q8h. Primary HSV infection-genital (Oral therapy): 200mg q4h while awake (5x/day) or 400mg po tid x 10 days. Recurrent genital: 400mg po tid x 5 days. Herpes Zoster: 800mg po q4h while awake (5x/day) x 7 days. If severe give 10-12 mg/kg IV q8h x 7-14 days. Chronic suppression (genital herpes): 400mg po bid. Zovirax ointment: apply ½" q3h (6 x/day).   

Renal Dosing:
50 - 90/ 5 to 12.4 mg/kg q8h || 10-50 / 5-12.4 mg/kg q12-24h || <10 / 2.5 to 6 mg/kg q24h. Alternatively: (Oral): 10-25 / dose q8h || <10 / dose q12h. (IV): 25-50/ 5-10mg/kg q12h || 10-25/ 5-10mg/kg q24h || <10/ 2.5 to 5mg/kg IV q24h. || HD: dose after dialysis || CAPD: see < 10.
 


 

 

Contact . Privacy PolicyDisclaimer

Copyright  © GlobalRPh Inc.